Koers Roche Holding Ltd. Swiss Exchange
Aandelen
CH0012032048
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- CHF | - |
|
Omzet 2024 * | 60,61 mld. 67,55 mld. 63,17 mld. | Omzet 2025 * | 64 mld. 71,33 mld. 66,7 mld. | Marktkapitalisatie | 202 mld. 225 mld. 210 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 13,25 mld. 14,77 mld. 13,81 mld. | Nettowinst (verlies) 2025 * | 14,76 mld. 16,45 mld. 15,38 mld. | EV/omzet 2024 * | 3,56 x |
Nettoschuld 2024 * | 14,09 mld. 15,7 mld. 14,68 mld. | Nettoschuld 2025 * | 9 mld. 10,03 mld. 9,38 mld. | EV/omzet 2025 * | 3,29 x |
K/w-verhouding 2024 * |
14,7
x | K/w-verhouding 2025 * |
13,3
x | Werknemers | - |
Dividendrendement 2024 * |
3,92% | Dividendrendement 2025 * |
4,03% | Vrij verhandelbaar | 88,91% |
Recentste transcriptie over Roche Holding Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-03 | |
Severin Schwan
CHM | Chairman | 57 | 01-01-08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01-04-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03-03-15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01-01-96 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,61% | 811 mld. | |
+44,25% | 640 mld. | |
-6,33% | 353 mld. | |
+20,62% | 333 mld. | |
+10,44% | 302 mld. | |
+18,45% | 246 mld. | |
+13,03% | 218 mld. | |
+8,61% | 168 mld. | |
-4,76% | 155 mld. |